Page last updated: 2024-11-03

procyclidine and Delirium of Mixed Origin

procyclidine has been researched along with Delirium of Mixed Origin in 3 studies

Procyclidine: A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism.
procyclidine : A tertiary alcohol that consists of propan-1-ol substituted by a cyclohexyl and a phenyl group at position 1 and a pyrrolidin-1-yl group at position 3.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Bellizzi, A1
Mercieca, E1
Dimech, C1
Van Kernebeek, MW1
Ghesquiere, M1
Vanderbruggen, N1
Verhoeven, E1
Hubloue, I1
Crunelle, CL1
Hughes, AR1
Moore, KK1
Mah, ND1
Birmingham, AR1
Clark, RK1
Thompson, JA1
Hendrickson, RG1

Other Studies

3 other studies available for procyclidine and Delirium of Mixed Origin

ArticleYear
Delirium secondary to anticholinergics.
    BMJ case reports, 2023, Jan-10, Volume: 16, Issue:1

    Topics: Antipsychotic Agents; Cholinergic Antagonists; Delirium; Hallucinations; Humans; Male; Procyclidine

2023
Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication.
    Clinical toxicology (Philadelphia, Pa.), 2021, Volume: 59, Issue:5

    Topics: Adult; Cholinergic Antagonists; Cholinesterase Inhibitors; Delirium; Humans; Male; Muscarinic Antago

2021
Letter in response to Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication.
    Clinical toxicology (Philadelphia, Pa.), 2021, Volume: 59, Issue:9

    Topics: Cholinergic Antagonists; Delirium; Humans; Muscarinic Antagonists; Procyclidine; Rivastigmine

2021